Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Iadeluca%2C+Laura%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Iadeluca%2C+Laura%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Iadeluca%2C+Laura%22&type=Person&sort=year
PubPharm (23)
1
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden
enthalten in:
Applied health economics and health policy
| 2023
von
Naik, J.
|
Beavers, N.
|
Nilsson, F.
| +2
Wird geladen...
2
Real-world study of next-generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
enthalten in:
Cancer science
| 2023
von
Takahashi, T.
|
Nishio, M.
|
Nishino, K.
| +6
Wird geladen...
3
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden
enthalten in:
Applied health economics and health policy
| 2023
von
Naik, J.
|
Beavers, N.
|
Nilsson, F.
| +2
Wird geladen...
4
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden
enthalten in:
Applied health economics and health policy
| 2023
von
Naik, J.
|
Beavers, N.
|
Nilsson, F.
| +2
Wird geladen...
5
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden
enthalten in:
Applied health economics and health policy
| 2023
von
Naik, J.
|
Beavers, N.
|
Nilsson, F.
| +2
Wird geladen...
6
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer
enthalten in:
Future oncology (London, England)
| 2023
von
Solomon, B.
|
Bauer, T.
|
K Mok, T.
| +15
Wird geladen...
7
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer : updated analysis of data from the phase 3, randomised, open-label CROWN study
enthalten in:
The Lancet. Respiratory medicine
| 2023
von
Solomon, B.
|
Bauer, T.
|
Mok, T.
| +15
CommentIn: Lancet Respir Med. 2023 Apr;11(4):302-304. - PMID 36535299
Wird geladen...
8
Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
enthalten in:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
| 2023
von
Smith, S.
|
Albuquerque de Almeida, F.
|
Inês, M.
| +2
Wird geladen...
9
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2022
von
Mazieres, J.
|
Iadeluca, L.
|
Shaw, A.
| +11
Wird geladen...
10
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC
enthalten in:
JTO clinical and research reports
| 2022
von
Wu, Y.
|
Lu, S.
|
Yang, J.
| +11
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
23
Aufsätze
20
E-Artikel
20
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
4
Applied health economics and health policy
4
PharmacoEconomics
4
Targeted oncology
3
Future oncology (London, England)
2
JTO clinical and research reports
1
Cancer management and research
1
Cancer science
1
Journal of multidisciplinary healthcare
1
Lung cancer (Amsterdam, Netherlands)
1
The Lancet. Respiratory medicine
1
Value in health : the journal of the Internatio...
Alle anzeigen ...
weniger ...
Thema
14
Journal Article
7
Crizotinib
7
EC 2.7.10.1
7
Protein Kinase Inhibitors
6
53AH36668S
6
OSP71S83EU
6
lorlatinib
5
Anaplastic Lymphoma Kinase
5
Lactams, Macrocyclic
4
Research Support, Non-U.S. Gov't
3
Observational Study
3
Protein-Tyrosine Kinases
3
Proto-Oncogene Proteins
2
Aminopyridines
2
NSCLC
2
ROS1
2
ROS1 protein, human
2
Randomized Controlled Trial
2
non-small-cell lung cancer
2
real-world evidence
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
21
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23
Englisch
Haven't found what you're looking for?
Wird geladen...